Skip to main content

Table 1 Characteristics of patients whose thymus were used for RT-PCR experiments

From: Decreased expression of miR-29 family associated with autoimmune myasthenia gravis

Patient ID Gender Age (years) Degree of thymic hyperplasia (1) Interval
onset - thymectomy (months)
MGFA score at thymectomy (2) Corticoid treatment Cholinesterase inhibitors Anti-AChR titer (nmol/L)
MG1 F 15 Low 13 III b No Yes 3.45
MG2 F 23 Low 7 II a No Yes 2118.7
MG3 F 29 Low 7 I a No NS 83.7
MG4 F 35 Low 24 IV a No Yes 11.1
MG5 F 20 Low 6 II a No Yes > 100
MG6 F 32 Low 6 II b No Yes 17.3
MG7 F 30 High 2 IV a No NS > 100
MG8 F 30 High 14 I No NS 3180.2
MG9 F 25 High 3 II a No Yes 3.21
MG10 F 28 High 4 II a No Yes 60.38
MG11 F 28 High 36 III a No Yes 9.7
MG12 F 22 High 2 III a No Yes 264
  1. (1) Degree of thymic hyperplasia: low hyperplasia (with 2 or fewer GCs per section) or high hyperplasia (with 3 or more GCs per section). (2) Clinical classification according to the Myasthenia Gravis Foundation of America (MGFA)